π° Global Impact Deals #2
This weekβs edition dives into the latest funding deals and groundbreaking advancements shaping the global impact landscape. From Pacific Fusion raising $900M to develop High-gain pulsed fusion tech to AbbVie acquiring Aliada Therapeutics for $1.4B.
Happy Monday π
This weekβs edition dives into the latest funding deals and groundbreaking advancements shaping the global impact landscape. From Pacific Fusion raising $900M to develop High-gain pulsed fusion tech to AbbVie acquiring Aliada Therapeutics for $1.4B, discover the key transactions and trends making waves in Education, Climate, Health, and Technology.
βοΈ Deal of the Week: Pacific Fusion, a fusion start-up, raised $900M in Series A funding to develop high-gain pulsed magnetic fusion technology.
What's New?
π Education. Personal learning, early childhood communication & virtual learning
π Climate. Fusion, transport & truckload transportation
π₯ Health. Biotechnology & biopharma
πͺ Space and Defense. Security services, weapons systems & defense tech
π» Technology. Cybersecurity & security governance
π Education
π Oboe, a US-based personalized learning company, raised a $4M seed from Eniac Ventures to finance the development of its platform and services.
πΆ Potentia, a private equity firm, acquired Storypark, a New Zealand-based early childhood communication platform, through an auction process led by RBC Capital Markets.
π¨βπ» Springpod, a provider of virtual work-based learning experiences for students, raised $2.5M in funding from American Student Assistance to expand virtual work-based learning.
π± Climate
π¨ Gold Fields, a South African gold producer, acquired Osisko Mining, a Canada-based mineral exploration company for $1.39B.
βοΈ Pacific Fusion, a US-based fusion start-up, raised $900M in Series A funding to develop high-gain pulsed magnetic fusion technology.
π Enterprise Products Partners, an energy company, has acquired PiΓ±on Midstream, a private midstream company for $950M.
π₯ Health
π¦ AbbVie acquired Aliada Therapeutics, MA-based biotechnology company for $1.4B to expand its pipeline of CNS drug development.
𧬠Seaport Therapeutics, a clinical-stage biopharmaceutical company, raised a $225M Series B to advance its lead drug candidate into clinical trials and further develop its Glyph technology platform.
π Kivu Bioscience, a CA-based biotech company, secured a $92M Series A from Novo Holding to advance multiple oncology programs in the clinic.
πͺ Space and Defense
π₯ Pye-Barker Fire & Safety, a fire protection and security services provider, acquired MS Fire Protection, a fire sprinkler servicer based in Fresno, California.
π Special Aerospace Services, a Space and defense solutions provider, acquired Concordia Technologies, a Hypersonic missile manufacturer that allows SAS to support national security missions.
βοΈ Origin, a Lativia-based defense technology company, raised $4.3M from Change Venture & Silicon Roundabout Ventures for battlefield-tested algorithmic weapons systems.
π» Technology
π Armis, a cybersecurity company, raised a $200M Series D from General Catalyst and Alkeon Capital, increasing its valuation to $4.3B as it aims for a potential initial public offering.
π Zenity, a security governance platform, raised a $38M Series B from Third Point Ventures and DTCP to grow the team across product, engineering, sales, and marketing, as well as launching a partner program
π΅οΈ Stream. Security, a cybersecurity company, raised a $30M Series B for its Cloud Twin technology that helps detect cloud threats.
Thank you for reading. Have a great week ahead!
Have some feedback or suggestions? Let us know at hello@holoniq.com